Actinium Pharmaceuticals, Inc.ATNMNYSE
Loading
Year-over-year SG&A expense growth
Percentile
P36
Within normal range
vs 3Y Ago
-0.3x
Contraction
Streak
2 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2024 | -9.41% |
| 2023 | 11.10% |
| 2022 | 48.56% |
| 2021 | 28.04% |
| 2020 | 23.65% |
| 2019 | -24.23% |
| 2018 | -26.46% |
| 2017 | -1.23% |
| 2016 | -19.15% |
| 2015 | 12.68% |